Showing 1 - 20 results of 73,965 for search '(( 5 ppm decrease ) OR ((( 5 ((nn decrease) OR (_ decrease)) ) OR ( a fold decrease ))))', query time: 1.07s Refine Results
  1. 1

    GREAT GO analysis of WDR5 and MYCN overlapped ChIP-seq peaks with >2.5-fold decrease of WDR5 signal intensity after the silencing of <i>WDR5</i>. by Zhihui Liu (95891)

    Published 2024
    “…<p>GREAT GO analysis of WDR5 and MYCN overlapped ChIP-seq peaks with >2.5-fold decrease of WDR5 signal intensity after the silencing of <i>WDR5</i>.…”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Synthesis of polymers 5 and 6. by Ghadeer Mubarak (21567569)

    Published 2025
    “…The results showed that AMCs act as efficient corrosion inhibitors, with over 90% inhibition efficiency ( ) at 20 ppm concentration. The electrochemical investigation results indicated that the AMCs with hydrophilic and hydrophobic ratios of 100 (<b>5</b>), 90:10 (<b>6a</b>), and 80:20 (<b>6b</b>) manifest of 87.74%, 92.12%, and 93.53%, respectively. …”
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

    Published 2019
    “…(B) Following 24 hours of treatment with FTY720, the proliferation of HuH6 cells measured using the CellTiter 96 cell proliferation assay was significantly decreased (IC<sub>50</sub> = 6.4 μM, p ≤ 0.05). (C) HuH6 cells were plated and allowed to reach 80% confluence, at which time the media was changed for fresh media (0, 5, or 8 μM FTY720) and a standard scratch wound was made. …”
  17. 17

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC<sub>(tofacitinib, 0–∞)</sub> and a 9.61-fold increase of colonic AUC<sub>(tofacitinib, 0–12h)</sub>, compared with tofacitinib at a molar equivalent oral dose. …”
  18. 18
  19. 19
  20. 20